Skip to main contentSkip to navigation
Sirius Investors
Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

AMPH
NASDAQHealthcare

Revenue Analysis - AMPH

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

AMPH Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Finished Pharmaceutical Products Segment

0.0% of total revenue

$0

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Product
3/31/2025$170.5M
12/31/2024$524.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Insufficient data for trend analysis

Geographic Regions

Stable Segments
UNITED STATES-7.3%
France0.0%
China0.0%

Earnings Reports

Want to see how AMPH's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports